National Mar 13, 2021
The drugmaker's vaccine, the only one OK'd by the health ministry so far, consists of two shots, meaning 100 million doses will be enough for 50 million people.
The drugmaker's vaccine, the only one OK'd by the health ministry so far, consists of two shots, meaning 100 million doses will be enough for 50 million people.
Vaccine comparison shopping hurts everyone
Medical professionals are holding out for some vaccines over others which are seen to have lower efficacy rates, risking delaying vaccination programs.
The shipment of up to 526,500 doses of the first vaccine against the novel coronavirus that Japan has approved for use was delivered to Narita Airport near Tokyo from Belgium.
Survey shows many of Japan's seniors are undecided about COVID-19 vaccines
A survey conducted on people who require home nursing care earlier this month showed 43% were unsure about receiving shots while 15% were against it entirely.
Pfizer-BioNTech shot could help end pandemic, Israel study shows
It was the largest study yet to quantify the impact of the vaccine outside the rigorous confines of a randomized, blinded clinical trial aimed at measuring effectiveness for regulators.
Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan
The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.
One shot or two? Japan weighs question as vaccine rollout stalls amid shortages
Health minister Norihisa Tamura says Japan will stick to the standard two-dose schedule, but some in the LDP are calling for a change of course.
Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows
The study provides the first real-world indication that the immunization will curb transmission of the coronavirus, but experts cautioned that more data is needed.
Pfizer’s vaccine works well after one dose and doesn’t always need ultracold storage
A study in Israel showed that the vaccine is robustly effective after the first shot, raising the possibility that regulators in some countries could authorize delaying a second dose.
Pfizer says South African variant could significantly reduce vaccine protection
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc.-BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. The study ...
This is what you need to know to get a coronavirus vaccine in Japan
More than two months after the U.K. and the U.S., Japan finally embarked on an unprecedented coronavirus vaccination blitz Wednesday.
Vaccination of health care workers to begin in Japan, with older people slated for April
Municipal governments are being encouraged to spend no longer than two months and three weeks to complete the phase of giving shots to older people.